Seguir
Marina Boccardi
Marina Boccardi
Dirección de correo verificada de dzne.de
Título
Citado por
Citado por
Año
Association of brain amyloidosis with pro-inflammatory gut bacterial taxa and peripheral inflammation markers in cognitively impaired elderly
A Cattaneo, N Cattane, S Galluzzi, S Provasi, N Lopizzo, C Festari, ...
Neurobiology of aging 49, 60-68, 2017
10172017
Strategic roadmap for an early diagnosis of Alzheimer's disease based on biomarkers
GB Frisoni, M Boccardi, F Barkhof, K Blennow, S Cappa, K Chiotis, ...
The Lancet Neurology 16 (8), 661-676, 2017
5992017
Quantitative comparison of 21 protocols for labeling hippocampal subfields and parahippocampal subregions in in vivo MRI: towards a harmonized segmentation protocol
PA Yushkevich, RSC Amaral, JC Augustinack, AR Bender, JD Bernstein, ...
Neuroimage 111, 526-541, 2015
3012015
Cortex and amygdala morphology in psychopathy
M Boccardi, GB Frisoni, RD Hare, E Cavedo, P Najt, M Pievani, ...
Psychiatry Research: Neuroimaging 193 (2), 85-92, 2011
2152011
The EADC‐ADNI harmonized protocol for manual hippocampal segmentation on magnetic resonance: Evidence of validity
GB Frisoni, CR Jack Jr, M Bocchetta, C Bauer, KS Frederiksen, Y Liu, ...
Alzheimer's & Dementia 11 (2), 111-125, 2015
2102015
Survey of protocols for the manual segmentation of the hippocampus: preparatory steps towards a joint EADC-ADNI harmonized protocol
M Boccardi, R Ganzola, M Bocchetta, M Pievani, A Redolfi, G Bartzokis, ...
Journal of Alzheimer's disease 26 (s3), 61-75, 2011
1732011
Frontotemporal dementia as a neural system disease
M Boccardi, F Sabattoli, MP Laakso, C Testa, R Rossi, A Beltramello, ...
Neurobiology of aging 26 (1), 37-44, 2005
1542005
Delphi definition of the EADC‐ADNI harmonized protocol for hippocampal segmentation on magnetic resonance
M Boccardi, M Bocchetta, LG Apostolova, J Barnes, G Bartzokis, ...
Alzheimer's & Dementia 11 (2), 126-138, 2015
1482015
Training labels for hippocampal segmentation based on the EADC‐ADNI harmonized hippocampal protocol
M Boccardi, M Bocchetta, FC Morency, DL Collins, M Nishikawa, ...
Alzheimer's & Dementia 11 (2), 175-183, 2015
1472015
The MRI pattern of frontal and temporal brain atrophy in fronto-temporal dementia
M Boccardi, MP Laakso, L Bresciani, S Galluzzi, C Geroldi, A Beltramello, ...
Neurobiology of aging 24 (1), 95-103, 2003
1472003
A harmonized segmentation protocol for hippocampal and parahippocampal subregions: Why do we need one and what are the key goals?
LEM Wisse, AM Daugherty, RK Olsen, D Berron, VA Carr, CEL Stark, ...
Hippocampus 27 (1), 3-11, 2017
1442017
Abnormal hippocampal shape in offenders with psychopathy
M Boccardi, R Ganzola, R Rossi, F Sabattoli, MP Laakso, ...
Human brain mapping 31 (3), 438-447, 2010
1332010
Alexithymia in healthy women: a brain morphology study
G Borsci, M Boccardi, R Rossi, G Rossi, J Perez, M Bonetti, GB Frisoni
Journal of Affective Disorders 114 (1-3), 208-215, 2009
1302009
Occipital sources of resting-state alpha rhythms are related to local gray matter density in subjects with amnesic mild cognitive impairment and Alzheimer's disease
C Babiloni, C Del Percio, M Boccardi, R Lizio, S Lopez, F Carducci, ...
Neurobiology of aging 36 (2), 556-570, 2015
1152015
Effects of hormone therapy on brain morphology of healthy postmenopausal women: a Voxel-based morphometry study
M Boccardi, R Ghidoni, S Govoni, C Testa, L Benussi, M Bonetti, G Binetti, ...
Menopause 13 (4), 584-591, 2006
1102006
European Association of Nuclear Medicine and European Academy of Neurology recommendations for the use of brain 18F‐fluorodeoxyglucose positron emission …
F Nobili, J Arbizu, F Bouwman, A Drzezga, F Agosta, P Nestor, Z Walker, ...
European journal of neurology 25 (10), 1201-1217, 2018
1072018
Clinical utility of FDG PET in Parkinson’s disease and atypical parkinsonism associated with dementia
Z Walker, F Gandolfo, S Orini, V Garibotto, F Agosta, J Arbizu, F Bouwman, ...
European Journal of Nuclear Medicine and Molecular Imaging 45, 1534-1545, 2018
1032018
The validation status of blood biomarkers of amyloid and phospho-tau assessed with the 5-phase development framework for AD biomarkers
NJ Ashton, A Leuzy, TK Karikari, N Mattsson-Carlgren, A Dodich, ...
European journal of nuclear medicine and molecular imaging 48, 2140-2156, 2021
982021
Clinical validity of cerebrospinal fluid Aβ42, tau, and phospho-tau as biomarkers for Alzheimer's disease in the context of a structured 5-phase development framework
N Mattsson, A Lönneborg, M Boccardi, K Blennow, O Hansson, ...
Neurobiology of aging 52, 196-213, 2017
982017
Local amygdala structural differences with 3T MRI in patients with Alzheimer disease
E Cavedo, M Boccardi, R Ganzola, E Canu, A Beltramello, C Caltagirone, ...
Neurology 76 (8), 727-733, 2011
972011
El sistema no puede realizar la operación en estos momentos. Inténtalo de nuevo más tarde.
Artículos 1–20